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The development of new subunit vaccines has promoted the rational design of adjuvants
able to induce a strong T-cell activation by targeting specific immune receptors. The
S-layer is a (glyco)-proteinaceous envelope constituted by subunits that self-assemble
to form a two-dimensional lattice that covers the surface of different species of Bacteria
and Archaea. Due to their ability to self-assemble in solution, they are attractive tools
to be used as antigen/hapten carriers or adjuvants. Recently, we have demonstrated
that S-layer glycoprotein from Lactobacillus kefiri CIDCA 8348 (SLP-8348) enhanced
the LPS-induced response on macrophages in a Ca2+-dependent manner, but the
receptors involved in these immunomodulatory properties remain unknown. Therefore,
we aim to determine the C-type lectin receptors (CLRs) recognizing this bacterial surface
glycoprotein as well as to investigate the role of glycans in both the immunogenicity
and adjuvant capacity of SLP-8348. Here, using a mild periodate oxidation protocol,
we showed that loss of SLP-8348 glycan integrity impairs the cell-mediated immune
response against the protein. Moreover, our data indicate that the adjuvant capacity of
SLP-8348 is also dependent of the biological activity of the SLP-8348 glycans. In order
to evaluate the CLRs involved in the interaction with SLP-8348 an ELISA-based method
using CLR–hFc fusion proteins showed that SLP-8348 interacts with different CLRs such
as Mincle, SingR3, and hDC-SIGN. Using BMDCs derived from CLR-deficient mice,
we show that SLP-8348 uptake is dependent of Mincle. Furthermore, we demonstrate
that the SLP-8348-induced activation of BMDCs as well as its adjuvant capacity
relies on the presence of Mincle and its signaling adaptor CARD9 on BMDCs, since
SLP-8348-activated BMDCs from Mincle−/− or CARD9−/− mice were not capable
to enhance OVA-specific response in CD4+ T cells purified from OT-II mice. These
findings significantly contribute to the understanding of the role of glycans in the
immunomodulation elicited by bacterial SLPs and generate a great opportunity in the
search for new adjuvants derived from non-pathogenic microorganisms.
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INTRODUCTION
Studies of the biotechnological applications of S-layer proteins,
considered as one of the most abundant biopolymers on our
planet (1), have been increasing in recent years. The S-layer
is a surface macromolecular array, found on both Gram-
positive and Gram-negative bacteria and highly prevalent
in archaea (2). It is generally formed by identical protein or
glycoprotein subunits that are held together by non-covalent
interactions and self-assemble to form a two-dimensional
lattice (3, 4). Since the S-layer constitutes the outermost
surface structure in those microorganisms, it is in direct
contact with the bacterial environment and could mediate
interactions with host cells. This feature, together with
the ability to self-assemble and its unique physicochemical
properties, make S-layer proteins (SLPs) an attractive tool
to use as antigen/hapten carrier, as adjuvant, or as part
of vaccination vesicles (1). Therefore, understanding how
SLPs interact with immune cells is a critical step toward
the application of these proteins in the development of new
adjuvanted vaccines.
It is known that upon recognition of microbial structures
through different pattern recognition receptors (PRRs), antigen
presenting cells (APCs) such as dendritic cells (DCs) and
macrophages, undergo signal transduction that lead to cell
maturation with the up-regulation of co-stimulatory molecules
and production of different chemokines and cytokines. There
are different classes of PRR families, including transmembrane
proteins such as Toll-like receptors (TLRs) and C-type lectin
receptors (CLRs) (5). TLRs are a family of membrane-bound
proteins that mainly recognize microbial membrane components
such as lipids, lipoproteins, and proteins (6). In contrast, CLRs
are specialized in the recognition of carbohydrates, through one
or more carbohydrate recognition domains (CRDs). Depending
on the receptors engaged, APCs display different maturation
states and produce different inflammatory mediators that impact
the following cellular and humoral responses (7, 8).
Lactobacillus kefiri is a lactic acid bacterium derived from
kefir, carrying an S-layer glycoprotein in its envelope (9–11). It
has been shown that L. kefiri has immunomodulatory properties,
and both in vitro and in vivo experiments support its potential as
a probiotic microorganism (12, 13). Moreover, the SLPs from L.
kefiri antagonize the effect of Clostridium difficile toxins on Vero
cells (14), mediate the inhibition of Salmonella enterica invasion
to Caco-2 cells (15) and they also enhance the adhesion of L. kefiri
to gastrointestinal mucus (16).
Glycosylation is the most frequent post-translational
modification found on SLPs (17). Some studies have been
conducted to address the role of the glycans present in the SLPs
from different Lactobacillus species in their immunomodulatory
properties. In LPS-treated immature dendritic cells, the SLP from
L. acidophilus NCFM was able to induce an anti-inflammatory
profile, mediated by the CLR DC-specific ICAM-3-grabbing
non-integrin (DC-SIGN) (18). Moreover, this SLP-DC-SIGN
engagement was demonstrated for S-layer like proteins from L.
plantarum (19) and was also suggested for the SLP from L. kefiri
JCM 5818 (20).
Recently, we have demonstrated that the S-layer glycoprotein
from Lactobacillus kefiri CIDCA 8348 (SLP-8348) was
internalized by macrophages in a process that was mediated
by carbohydrate-receptor interactions. In addition, SLP-8348
enhanced the LPS-induced response on macrophages in a Ca+2-
dependent manner (21). However, the molecular mechanisms
as well as the receptors involved in the immunomodulatory
properties elicited by SLP-8348 onAPCs are not well-understood.
Thus, the aim of this work was to investigate the involvement of
CLRs in the immune cell response to SLP-8348 using in vitro and
in vivo approaches.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
L. kefiri CIDCA 8348 isolated from kefir grains was used (22).
The strain was cultured in de Man-Rogosa-Sharpe (MRS) broth
(Difco, Beauvais, France) at 37◦C for 48 h in aerobic conditions.
Frozen stock cultures were stored at −80◦C in skim milk
until use.
S-Layer Protein Extraction
S-layer protein extraction from bacterial cells at stationary phase
was performed using 5M LiCl as previously described (14). SLPs
extracts were tested by sodium dodecylsulphate-polyacrylamide
gel electrophoresis (SDS-PAGE) in 12% separating and 4%
stacking gels using the discontinuous buffer system according to
Laemmli (23). Gels were migrated on a BioRad Mini-Protean II
(BioRad Laboratories, Richmond, CA, USA) and revealed using
Colloidal Blue Staining. Carbohydrate glycol groups present
in SLP-8348 were oxidized with sodium periodate (10mM) as
previously described by Rodriguez et al (24). The oxidation
was performed at room temperature for 45min in the dark,
followed by the reduction with sodium borohydride (50mM) of
the reactive aldehyde groups (24). The resulting oxidized SLP
is referred as SLPOx-8348. The control, SLPB-8348, consisted
of SLP-8348 subjected to the whole treatment excepting for the
incubation with sodium periodate. SLPs were dialyzed against
PBS and then filtrated through a membrane of 0.45µm pore
diameter. Protein concentration was determined according to
Bradford (25).
Cell Cultures
The monocyte/macrophage murine cell line RAW 264.7 was
cultured in Dulbecco’s Modified Eagle Medium (DMEM)
supplemented with: 10% (v/v) heat-inactivated (30 min/60◦C)
fetal bovine serum (FBS), 1% (v/v) non-essential amino acids and
1% (v/v) penicillin-streptomycin solution (100 U/mL penicillin
G,100 g/mL streptomycin). All cell culture reagents were from
GIBCO BRL Life Technologies (Rockville, MD, USA).
BMDCs were generated from C57BL/6 wild type, Mincle −/−,
CARD9 −/−, or SignR3 −/− bone marrow precursors (2.5 × 105
cells/ml) that were plated in complete culture medium (IMDM
supplemented with 2mM glutamine, 10% (v/v) FBS, 100 U/ml
penicillin and 100µg/ml streptomycin) supplemented with a
GM-CSF containing supernatant from P3-X63 cells. Mediumwas
exchanged every 48 h and BMDCs were used after 8–10 days
Frontiers in Immunology | www.frontiersin.org 2 June 2019 | Volume 10 | Article 1422
Malamud et al. S-Layer Glycoprotein Immunostimulation Through Mincle
of differentiation to ascertain that ≥80% of the cell population
expressed the marker CD11c.
Binding and Internalization of SLP-8348 by
BMDCs
Binding and internalization of SLP-8348 were analyzed by flow
cytometry. Labeling of SLP-8348 with Atto 647N was performed
according to the manufacturer’s instructions (SIGMA, USA).
BMDCs from C57BL/6 mice, Mincle-deficient and SignR3-
deficient mice (2.5 × 105/mL) were incubated with Atto 647
N-labeled SLP-8348 for 1 h at 37◦C (to assess uptake), or at 4◦C
in complete medium (to assess binding) (21, 24). Cells were
then washed, incubated with mouse anti-CD11c antibody and
analyzed by flow cytometry.
Cells Stimulation Assays
RAW 264.7 cells (2.5 × 105) were distributed onto 24-well
microplates (JET BIOFIL R©, China), and the medium volume
was adjusted to 0.5mL. The plates were incubated for 48 h at
37◦C in a 5% CO2 95% air atmosphere to allow cell adherence
prior to experimentation. After that, cells were treated with
SLP-8348 (10µg/mL), SLPOx-8348 (10µg/mL) or SLPB-8348
(10µg/mL) in the presence or absence of LPS 0.1µg/mL (LPS
from Escherichia coliO111:B4, SIGMA, USA), in DMEM for 24 h
at 37◦C in a 5% CO2 95% air atmosphere. Cells incubated with
DMEM were used as negative control.
BMDCs from wild type or CLR-deficient mice (1 × 105
cells/well) were distributed onto 96-well microplates (Sarstedt,
Germany) and stimulated with SLP-8348 (10µg/mL), LPS
(0.25µg/mL) or the combination of both for 16 h at 37◦C in a
5%CO2 95% air atmosphere. Culture supernatants were collected
and analyzed by ELISA for IL-6 and TNF-α secretion. Cells
were incubated with anti-CD16/32 (93) to block cell surface
FcγRII/RIII receptors, stained with anti-CD11c (N418), CD40
(3/23), CD80 (16-10A1) and then analyzed by flow cytometry.
Mice
For in vivo experiments, 6- to 8-week-old female BALB/c mice
were purchased from the Animal Care Facility of the Facultad
de Ciencias Veterinarias of the Universidad Nacional de La Plata
(Argentina) or DILAVE Laboratories (Uruguay). Animals were
kept in the animal house (Cátedra de Microbiología, Facultad de
Ciencias Exactas, UNLP, La Plata, Argentina or URBE, Facultad
de Medicina, UdelaR, Montevideo, Uruguay) with water and
food supplied ad libitum, and handled in accordance with
institutional guidelines for animal welfare.
C57BL/6, C57BL/6-Tg (TcraTcrb)425Cbn/J mice (OT-II
transgenic mice), Mincle −/−, CARD9 −/− or SignR3 −/− were
kept in the animal house of the University of VeterinaryMedicine
(Hannover, Germany) with water and food supplied ad libitum.
Mice were sacrificed for the isolation of spleen cells (OT-II
transgenic mice) or the preparation of bone marrow for BMDC
generation (Mincle−/−, CARD9−/−, SignR3−/−, and WTmice).
BMDC/T Cell Co-culture Assay
Splenocytes were isolated fromOT-II transgenic mice by flushing
the spleen with complete IMDMmedium. After erythrocyte lysis,
cells were resuspended in MACS buffer (0.5% (w/v) BSA, 2mM
EDTA in PBS). T cells were obtained by magnetic-activated
cell separation (MACS) using Pan T cell isolation kit II, mouse
(Miltenyi Biotech, Bergisch Gladbach, Germany) according to
the manufacturer’s instructions. T cells were labeled with CFSE
(carboxyfluorescein diacetate succinimidyl ester, Sigma-Aldrich,
USA) and seeded on a 96-well round bottom culture plate (7 ×
104 cells/well). After 30min, BMDCs treated with OVA (Endo
Grade R© Ovalbumin, LIONEX GmbH, Germany) or OVA/SLP-
8348 were added and incubated for 72 h. Culture supernatants
were collected for IFN-γ secretion.
Immunization
To test the SLP-8348 immunogenicity, BALB/c mice (8 weeks
old, 5 mice per group) were subcutaneously injected on the
base of the tail with one dose of PBS, SLP-8348 (10 µg/mouse),
SLPOx-8348 (10 µg/mouse), SLPB-8348 (10 µg/mouse), OVA
(10 µg/mouse) or the combinations of them, with or without
IFA. After 10 days cells from inguinal lymph nodes were labeled
with CFSE and stimulated in vitro with SLP-8348 (10µg/ml) or
OVA (10µg/ml) for 5 days. Experimental protocol was approved
by the Institutional Animal Care and Use Committee of the
Facultad de Ciencias Exactas, Universidad Nacional de La Plata
(Protocol 006-00-18).
C-Type Lectin Receptor Recognition of
S-Layer Protein
The CLR-reactivity on SLP-8348 was evaluated by ELISA (26).
A half-area microplate (Greiner Bio-One GmbH, Frickenhausen,
Germany) was coated with 0.25 µg SLP-8348, SLPOx-8348, or
SLPB-8348 per well for 16 h at 4◦C and blocked with 1% (w/v)
BSA (Thermo Fisher Scientific, Darmstadt, Germany) for 2 h
at room temperature (RT). Then, 0.25 µg of each CLR-hFc
fusion protein in lectin-binding buffer (50mM HEPES, 5mM
MgCl2, and 5mM CaCl2) was added and incubated for 1 h at
RT. For inhibition assays, CLR-hFc fusion proteins were pre-
incubated with 5mM of EGTA (Sigma-Aldrich, USA). After
washing, HRP-conjugated anti-human IgG antibody (Dianova)
was added to each well for 1 h at RT. Finally, plates were
incubated with chromogenic substrate (o-phenylenediamine
dihydrochloride substrate tablet (Thermo Fisher Scientific),
24mM citrate buffer, 0.04% (v/v) H2O2, 50mM phosphate buffer
in H2O). The reaction was stopped with 2.0M sulfuric acid and
the plate was read at 495 nm using a Multiskan Go microplate
spectrophotometer (Thermo Fisher Scientific).
Cytokine Quantification in Cell Culture
Supernatants
Production of IL-6 by macrophages and IFN-γ by cells from
inguinal lymph nodes were analyzed by sandwich ELISA using
commercially available capture and detection antibodies from
BD-Pharmingen (San Diego, USA). Secretion of IL-6 and TNF-
α by BMDCs and IFN-γ from purified T cells were analyzed
by ELISA from PeproTech (USA). The assays were performed
according to the manufacturer’s instructions. After determining
optical densities, cytokine levels in cell culture supernatants were
calculated using the GraphPad Prism 6.0 program.
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Immunocytostaining and Flow Cytometry
After stimulation experiments, cells were washed twice with PBS
containing 2% (v/v) FBS and then labeled with specific antibodies
for 30min at 4◦C. Cells were washed twice with PBS containing
2% (v/v) FBS, and then fixed with 1% (v/v) formaldehyde. Cells
were analyzed using a FACSCalibur Analyzer (BD Biosciences),
Accuri C6 (BD Biosciences) or Attune NxT Flow Cytometer
(Thermo Fisher Scientific). Data analysis was performed using
the FlowJo Software (FlowJo, Ashland, OR, USA).
Statistical Analysis
Statistical analysis was performed with the GraphPad
Prism program. Values from at least three independent
experiments were analyzed by using a one-way or two-way
ANOVA with Tukey’s post hoc test (p < 0.05 was considered
statistically significant).
RESULTS
SLP-8348 Glycan Moieties Modulate the
TLR-Induced Maturation of Macrophages
Previous studies performed in our laboratory demonstrated
the capacity of SLP-8348 to enhance in vitro TLR-induced
maturation of murine macrophages in a Ca+2-dependent
manner (21). In order to determine if the carbohydrates
from SLP-8348 participate in the induction of high levels
of macrophage activation, we performed a mild periodate
oxidation of glycans where the glycol groups in carbohydrates
are oxidized to reactive aldehyde groups, which are in turn
reduced with sodium borohydride. During this process, the
glycans and the integrity of glycoproteins are maintained,
but instead the molecular conformation of the glycans is
altered, losing possible biological activity (24). Macrophages
stimulated with oxidized S-layer protein (SLPOx-8348) and
LPS produced similar levels of IL-6 as well as a comparable
expression of co-stimulatory molecules CD40 and CD86
as cells incubated with LPS alone (Figure 1). Macrophages
incubated with the control SLPB-8348 and LPS, developed
the same stimulation profile as cells in presence of LPS
and SLP-8348, with higher levels of IL-6, CD40 and
CD86 compared to LPS-treated macrophages (Figure 1).
These results indicate that terminal glycans present on
SLP-8348 determine the immunostimulatory activity on
LPS-matured macrophages.
Glycan Oxidation Impairs the
Immunogenicity of SLP-8348
In order to analyse SLP-8348 immunogenicity, one dose (10
µg/mouse) of SLP-8348 in combination with incomplete
Freund’s adjuvant (IFA) was subcutaneously injected into
BALB/c mice and antigen specific T-cell proliferation in
inguinal lymph nodes was evaluated 10 days post-injection.
CD4+ T cells proliferation index as well as secretion of
IFN-γ were significantly higher in the group of mice
treated with SLP-8348/IFA respect to PBS/IFA-treated
mice, after ex vivo stimulation with SLP-8348 (Figure 2A;
Supplementary Figure 1). Surprisingly, when the experiments
were performed in the absence of IFA, the group of mice
treated with SLP-8348 alone exhibited similar responses as
SLP-8348/IFA-treated mice, indicating that SLP-8348 is a highly
immunogenic glycoprotein able to induce T cell proliferation
and cytokine production in absence of adjuvant (Figure 2A;
Supplementary Figure 1).
In order to establish whether the glycan structures present on
SLP-8348 participate in the induction of a cell-mediated immune
response, we evaluated the T-cell proliferation in inguinal lymph
nodes frommice subcutaneously injected with SLP-8348, SLPOx-
8348, or SLPB-8348. CD4+ T cell proliferation index as well as
secretion of IFN-γ were significantly lower in the group of mice
treated with SLPOx-8348 compared to SLP-8348-treated mice,
after ex vivo stimulation with SLP-8348 (Figure 2B). The group
of mice treated with SLPB-8348 displayed a similar response
as SLP-8348-treated mice. These results indicate that SLP-8348
carbohydrates play an important role in the SLP-8348-induced T
cell stimulation.
Loss of Glycan Integrity Abrogates the
Adjuvant Capacity of SLP-8348
Having shown that immunization with SLP-8348 can induce
a specific cell-mediated immune response, and the crucial
role of the carbohydrates of SLP-8348 in that effect, we
subsequently explored the adjuvant potential of SLP-8348 using
OVA as a model antigen. In order to evaluate the in vivo
adjuvant capacity of SLP-8348, we injected subcutaneously
OVA or OVA/SLP-8348 on BALB/c mice and after 10 days,
cells from the inguinal lymph nodes were stimulated in vitro
with OVA. Proliferation index of CD4+ T cells as well as
secretion of IFN-γ against OVA were significantly higher in
the group of mice treated with the combination of SLP-8348
and OVA compared to OVA-treated mice (Figures 3A,B). To
determine if the carbohydrates from SLP-8348 participate in
the enhanced response against OVA, we carried out the same
experiments using the combination of SLPOx-8348 and OVA.
The proliferation index of CD4+ T cells as well as secretion
of IFN-γ against OVA were significantly lower in the group
of mice treated with OVA/SLPOx-8348 compared to OVA/SLP-
8348-treated mice (Figures 3A,B), indicating that oxidation of
glycans abrogates the adjuvant capacity of SLP-8348. Levels of
IFN-γ in absence of in vitro OVA stimulation are shown as
Supplementary Figure 2.
SLP-8348 Interacts With Different C-Type
Lectin Receptors
In order to identify possible CLRs that recognize SLP-8348,
we performed an ELISA-based method using CLR–hFc fusion
proteins (26). As shown in Figure 4A, glycoconjugates from
SLP-8348 strongly reacted with Mincle, as well as with
other receptors such as SignR3, hDC-SIGN and mLangerin.
Taking into account that all the CLRs tested in this work
recognized glycan structures in a Ca2+-dependent manner,
we incubated the CLR-hFc fusion protein with SLP-8348 in
the presence of EGTA. We observed that around 70% of
the SLP-8348/CLR-hFc binding was abrogated with EGTA
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FIGURE 1 | Glycans from SLP-8348 modulate TLR-induced maturation of macrophages. IL-6 concentrations (pg/mL) by capture ELISA in the supernatant of the
murine RAW 264.7 cultures after 24 h of stimulation (A). Percentage of CD40+ and CD86+ RAW 264.7 cells after 24 h of stimulation (B). A representative figure of
three independent experiments is shown (±SD, indicated by error bars). Asterisks indicate statistically significant differences by one-way ANOVA with Tukey’s post hoc
test (*p < 0.05).
FIGURE 2 | Glycan residues are crucial in SLP-8348 immunogenicity. Cells from inguinal lymph nodes were obtained from BALB/c mice subcutaneously injected with
one dose (10 µg/mouse) of SLP-8348 or PBS in combination or not with incomplete Freund’s adjuvant. IFN-γ levels on supernatants and proliferation index of CD4+
T cells (calculated as the ratio between the percentage of CFSE low CD4+ cells and CFSElow CD4+ cells from PBS+IFA-treated mice) were measured after
stimulation with SLP-8348 (10µg/ml) for 5 days (A). The same experiment was performed using SLP-8348, oxidized SLP-8348 (SLPOx-8348), and oxidation
negative control (SLPB-8348) in the absence of adjuvant. IFN-γ levels in supernatants and proliferation index of CD4+ T cells (calculated as the ratio between the
percentage of CFSE low CD4+ cells and CFSElow CD4+ cells from PBS-treated mice) were measured after stimulation with SLP-8348 (10µg/ml) for 5 days (B). A
representative figure of three independent experiments is shown (±SD, indicated by error bars). Asterisks indicate statistically significant differences by one-way
ANOVA with Tukey’s post hoc test (*p < 0.05).
incubation. Additionally, a ∼50% decrease was observed in
the binding of SLPOx-8348 to the CLR-hFc fusion proteins
compared to SLP-8348 (Supplementary Figure 3). All these
findings confirm that the glycans present in SLP-8348 participate
in the recognition by these CLRs in a Ca2+-dependent
manner (Figure 4A).
After establishing the recognition pattern of CLRs on SLP-
8348, we investigated whether this SLP-8348/CLRs engagement
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FIGURE 3 | The adjuvant capacity of SLP-8348 is a glycan-mediated process. BALB/c mice were subcutaneously injected with one dose (10 µg/mouse) of
SLP-8348 + OVA, oxidized SLP-8348 (SLPOx-8348) + OVA, PBS + OVA (OVA), or PBS (PBS). Cells were labeled with CFSE and stimulated in vitro with OVA
(10µg/ml) for 5 days. Proliferation index of CD4+ T cells in each experimental group was calculated as the ratio between the percentage of CFSE low CD4+ cells and
CFSElow CD4+ cells from OVA-treated mice (A). IFN-γ levels in supernatants (B). A representative figure of three independent experiments is shown (±SD, indicated
by error bars). Asterisks indicate statistically significant differences by one-way ANOVA with Tukey’s post hoc test (*p < 0.05).
FIGURE 4 | SLP-8348 is recognized and internalized by specific CLRs expressed on BMDCs. CLR-hFc fusion proteins were analyzed for the interaction with
SLP-8348. Inhibition assays were performed using EGTA, a Ca2+ chelating agent (A). Binding (4◦C, squares) and internalization (37◦C, circles) of Atto
647N-labeled-SLP-8348 at different concentrations on CD11c+ cells from C57BL/6 mice and CLR-deficient mice (B) A representative figure of three independent
experiments is shown (±SD, indicated by error bars). Asterisks indicate statistically significant differences by one-way ANOVA with Tukey’s post hoc test (*p < 0.05).
could induce internalization into BMDCs. To this end, Atto-
647-labeled SLP-8348 was incubated with BMDCs from C57BL/6
wild type mice or CLR-deficient mice both at 4◦C and 37◦C and
the fluorescence intensity was determined by flow cytometry.
As shown in Figure 4B, SLP-8348 both interacted with BMDCs
and was internalized by them. We found that SLP-8348
internalization was significantly reduced into BMDCs derived
from Mincle−/− mice but not from SignR3−/− mice, indicating
that the SLP-8348 uptake partially depends on glycan recognition
by Mincle.
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SLP-8348 Induce Maturation of BMDCs
Through Mincle Recognition
To address the immunomodulatory properties of SLP-8348,
we incubated SLPs with BMDCs from C57BL/6 wild type
mice. After 24 h of incubation, SLP-8348 was able to induce
increased levels of IL-6 and TNF-α, as well as the expression of
CD40 and CD80 (Figures 5A,B). The same effect was observed
using the combination of LPS and SLP-8348, generating higher
levels of IL-6 and TNF-α, as well as higher expression of the
costimulatory molecules CD40 and CD80 than LPS-stimulated
BMDCs (Figures 5A,B).
Given the capacity of Mincle to recognize and internalize
SLP-8348, we investigated whether this receptor or its adaptor
protein CARD9 mediated the innate response to SLP-8348 in
BMDCs. To this end, BMDCs derived from C57BL/6 wild type
mice, Mincle-deficient mice, CARD9-deficient mice and SignR3-
deficient mice were incubated overnight with SLP-8348, LPS or
the combination of both. The absence of Mincle or CARD9
signaling on BMDCs resulted in a significantly reduced IL-6
and TNF-α production as well as CD40 and CD80 expression
upon SLP-8384 stimulation compared to SignR3 or wild type
BMDCs (Figures 5C,D). The same effect was observed using the
combination of LPS and SLP-8348, demonstrating that Mincle
and its signaling adaptor CARD9 contribute to the stimulation
triggered by SLP-8348 and the modulation elicited by SLP-8348
on LPS-treated BMDCs (Figures 5C,D).
To further investigate whether the enhanced activation
elicited by SLP-8348 affected their T-cell stimulatory function,
we incubated OVA-treated BMDCs from wild type, Mincle−/−,
CARD9−/−, and SignR3−/− mice in the presence or absence
of SLP-8348 with purified T cells from OT-II mice. Our results
showed that SLP-8348 could enhance the OVA-specific T cell
proliferation, since the simultaneous stimulation with OVA and
SLP-8348 of BMDCs generated a higher IFN-γ production as well
as higher CD4+ T cell proliferation compared to OVA-treated
BMDCs (76.2 vs. 57.0%, respectively) (Figure 6A). Furthermore,
the proliferation index of CD4+ T cell as well as the IFN-
γ levels were significantly reduced when CD4+ T cells from
OT-II mice were incubated with OVA/SLP-8348-treated BMDCs
derived from Mincle−/− mice or CARD9−/− mice, compared
to the same treatment using BMDCs derived from wild type or
SignR3−/− mice (Figure 6B). These results clearly indicate that
Mincle and CARD9 signaling mediate an enhanced OVA-specific
response induced by SLP-8348 on BMDCs.
DISCUSSION
Studies of the biological role that carbohydrates play in
bacterial glycoproteins have been increasing over time. In fact,
the ability to modify proteins by adding carbohydrates was
considered exclusive of eukaryotic cells until the appearance
of studies on bacterial S-layer glycoproteins (27–29). The
attention that these proteins have gained derives from their
exceptional physicochemical properties rendering them a unique
organizational structure with high application potential in
different areas of modern nanobiotechnology. Taking into
account that in our previous report we demonstrated that SLP-
8348 could enhance the proinflammatory response on LPS-
stimulated macrophages in a Ca+2-dependent manner (21),
we first wanted to analyse the role of the carbohydrates
in this process. In this respect, the chemical oxidation of
terminal glycans has been probed as an adequate strategy
trying to understand the role of glycans in the regulation of
host immunity (24). When SLP-8348 was treated with meta-
periodate and used to stimulate LPS-treated macrophages,
the levels of secreted IL-6 as well as the expression of
CD40 and CD80 decreased to those corresponding to the
stimulation with LPS alone, indicating that the carbohydrates
present on SLP-8348 modulate the TLR-induced maturation
of macrophages.
In order to characterize more in detail the immunological
properties of SLP-8348, we focused on the study of the
antigen specific T-cell proliferation after a single subcutaneous
inoculation of SLP-8348. Our results demonstrate the capacity
of SLP-8348 to induce a high T-cell proliferation and the
production of IFN-γ, either in the presence or absence of
adjuvant. The immunogenicity of a Lactobacilli SLP was also
demonstrated by Kajikawa and colleagues, who showed that after
repeated high dose intragastric immunization with L. acidophilus
NCFM, specific antibodies against SlpA were generated (30).
To gain insight in the SLP-8348 glycan-mediated immune
response in vivo, we took advantage of the chemical oxidation
approach and performed the same experiments with SLPOx-
8348. Our results clearly demonstrate that the immunogenicity
of SLP-8348 is based on the carbohydrates linked to the
glycoprotein, since the re-stimulation of inguinal lymph nodes
derived-cells of SLPOx-8348-treated mice with purified SLP-
8348 induced lower levels of IFN-γ and lower proliferation
index of CD4+ T cells compared to SLP-8348-treated mice. This
role of the glycan structures on the immune response elicited
by bacterial glycoproteins was also demonstrated by Horn and
colleagues, who showed that the immune stimulation elicited by
mannosylated Apa glycoproteins ofMycobacterium spp. relies on
the presence of the glycan component and also on the extent of
glycosylation (31).
Vaccine adjuvants have traditionally been defined as materials
that enhance the immune response to vaccine antigens (32).
Beyond the mechanism of action, it appears that adjuvants
activate innate immune responses to create a local immuno-
competent environment at the injection site and draining lymph
nodes, that is required to enhance adaptive immunity to the co-
administered antigen (32, 33). In accordance with our results,
SLP-8348 was able to generate a cell-mediated immune response
in the draining lymph node after a subcutaneous injection.
Therefore, we decided to evaluate the in vivo adjuvant capacity
of SLP-8348 using OVA as model antigen. In OVA/SLP-8348-
immunized mice, the expansion of OVA-specific T cells and
the production of IFN-γ were significantly higher than in the
group of mice immunized with OVA alone, showing that SLP-
8348 could enhance the activation and differentiation of T
cells. This adjuvant capacity of SLP-8348 was also dependent
on the biological activity of the SLP-8348 glycans, since the
co-administration of OVA and metaperiodate treated-SLP-8348
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FIGURE 5 | SLP-8348-induced activation of BMDCs is Mincle-dependent. BMDCs from C57BL/6 mice were stimulated with SLP-8348, LPS or the combination of
both for 24 h. Culture supernatants and cells were collected and analyzed for the levels of IL-6 and TNF-α and for the cell surface expression of CD40 and CD80,
respectively (A,B). BMDCs from Mincle−/− mice, CARD9−/− and SignR3−/− mice were stimulated with SLP-8348, LPS or the combination of both for 24 h. Culture
supernatants were collected and analyzed by ELISA for IL-6 and TNF-α (C). Cells were collected and cell surface expression of CD40 and CD86 on CD11c+ cells
were analyzed by Flow cytometry (D) A representative figure of three independent experiments is shown (±SD, indicated by error bars). Asterisks indicate statistically
significant differences by two-way ANOVA with Tukey’s post hoc test (*p < 0.05); n.s: not significant; KO: knock-out.
induced a similar adaptive cellular immune response as the
administration of OVA alone. Even though previous studies have
demonstrated the adjuvant capacity of SLPs from Lactobacillus
strains (34), this is the first report showing the real participation
of the glycan moieties since the loss of the integrity of terminal
glycans completely abrogated the effect. Further studies will
be needed in order to test the potential antigenicity of the
SLP-8348 in this immunization protocol since it could affect
its adjuvanticity.
The evaluation of the adjuvant mechanism of action is a
crucial step in the development of effective human vaccines.
In this respect, the important role of the glycans in the
adjuvant capacity of SLP-8348 led us to study the CLRs that
could recognize this glycoprotein. The glycan moieties expressed
on SLP-8348 were strongly recognized by the macrophage
inducible C-type lectin receptor (Mincle) and to a lesser
extent by human DC-SIGN and its murine ortholog SignR3.
It was previously reported that binding of SlpA from L.
acidophilus NCFM to DC-SIGN on human BMDCs (18)
or to murine SignR3 (35) is responsible for induction of
immunoregulatory signals triggered by the SLP. Also, it was
recently reported that Mincle is involved in both the recognition
and the immune modulation elicited by the SLP from the
oral pathogen Tannerella forsythia (36). Since the ELISA-
based method used to detect the binding of SLP-8348 with
CLR-Fc fusion proteins can lead to false-positive results, it
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FIGURE 6 | Interaction between SLP-8348 and Mincle favors the adjuvanticity of SLP-8348. BMDCs from C57BL/6 mice were stimulated with SLP-8348, OVA or the
combination of both for 24 h. Cells were collected and exposed to CFSE-labeled CD4+ T cells from OT-II mice. Proliferation of CD4+ T cells (evaluated on
CFSE-stained CD4+T cells) and IFN-γ levels in supernatants were measured after 5 days (A). The same experiment was performed using BMDCs from CLR-deficient
mice. Proliferation index of CD4+ T cells within each experimental group was calculated as the ratio between the percentage of CFSE low CD4+ cells and CFSElow
CD4+ cells from OVA-treated BMDCs (B) A representative figure of three independent experiments is shown (±SD, indicated by error bars). Asterisks indicate
statistically significant differences by two-way ANOVA with Tukey’s post hoc test (*p < 0.05).
requires confirmation by additional methods (26). Therefore,
after establishing the recognition pattern of CLRs on SLP-
8348 we investigated the biological role of the SLP-8348/CLRs
engagement. Our results indicate that BMDCs could internalize
SLP-8348 in a Mincle-dependent fashion, since the absence
of this receptor on the cell surface of BMDCs reduced the
uptake of SLP-8348. In contrast, although SignR3 recognize SLP-
8348 glycans, this CLR does not mediate the internalization of
the glycoprotein.
To elucidate the mechanism that could explain the adjuvant
capacity of SLP-8348 we performed in vitro studies employing
GM-CSF derived BMDCs which, according to the literature,
represent amixture of DCs, macrophages, and (few) granulocytes
(37). SLP-8348 was able to induce a maturation of BMDCs from
wild type mice, with production of IL-6, TNF-α and the up-
regulation of the co-stimulatory molecules CD80 and CD40.
When BMDCs were exposed to a simultaneous stimulation with
SLP-8348 and LPS, we observed an increased response compared
to LPS-stimulated cells. These results partially agree with our
previous results, since SLP-8348 did not induce a macrophage
activation using RAW 264.7 cells by itself but could enhance the
response to stimulation with E. coli LPS (21), showing that the
same stimulus could trigger different responses depending on
the cell type, origin and polarization (38). We demonstrate that
SLP-8348 induced maturation of BMDCs in a Mincle-dependent
process, since the lack of this receptor generated a significant
reduction of the levels of IL-6, TNF-α and co-stimulatory
molecules. In addition, our results indicate that CARD9 is
also involved in the proinflammatory response elicited by SLP-
8348 on BMDCs. CARD9 is a caspase recruitment domain-
containing signaling protein that is involved in the signaling
pathway of ITAM-coupled receptors in myeloid cells, such as
Mincle (39–41). Previous studies have shown that the stimulation
of macrophages with the mycobacterial glycolipid trehalose-6,6′-
dimycolate (TDM), a well-known ligand of Mincle, leads to
NF-κB activation via the FcRγ/Syk/CARD9 pathway and results
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in production of proinflammatory cytokines and chemokines
such as TNF-α, CXCL2, CXCL1, and IL-6 (41, 42). Moreover,
Schoenen et al have demonstrated that Mincle is necessary for
the induction of adaptive immunity using a synthetic analog of
TDM as an adjuvant (42). More recently, Shah et al. showed
that a synthetic glycolipid (analog to the GL1 from Lactobacillus
plantarum) is able to signal through Mincle using a NFAT-
GFP reporter cell line (43). By carrying out OVA-specific T-
cell proliferation assays using BMDCs from Mincle-deficient
and CARD9-deficient mice, we demonstrate that Mincle and its
signaling adaptor CARD9 mediate the adjuvant capacity of SLP-
8348. CARD9 is involved in the signaling pathway of different
CLRs (39). The phenocopy of Mincle−/− and CARD9−/−
BMDCs strongly suggests that Mincle is a CLR that is involved
in the immunomodulatory activity of SLP-8348. It has been
shown that Mincle can interact with ligands of diverse chemical
origin (43–46). In this regard, further studies are needed to
determine the glycan structure of L. kefiri CIDCA 8348, in
order to characterize the nature of the carbohydrate residues
specifically recognized by Mincle.
In conclusion, we have demonstrated that SLP from L. kefiri
CIDCA 8348 is able to enhance the OVA-specific immune
response by triggering maturation of antigen presenting
cells through the recognition of glycan moieties by Mincle.
These results constitute a significant contribution to the
understanding of the role of glycans in the immunomodulation
elicited by bacterial SLPs and generate a promising
opportunity in the search for new adjuvants derived from
non-pathogenic microorganisms.
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